High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$968K
$968,360
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$90,177
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $90,177 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$2,669
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $2,669 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-02-02
$52,323
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $52,323 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Discretionary SellΔOwn -16.2%
2025-11-06
$732,927
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Discretionary SellΔOwn -16.2%
|
2025-11-06 | $732,927 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2025-10-02
$84,092
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-10-02 | $84,092 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2025-10-02
$6,172
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-10-02 | $6,172 | S | Form 4 |